Natreon Healthy Skin Study - PrimaVie Supplement
Public ClinicalTrials.gov record NCT02762032. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Ability of an Oral Supplement to Improve Skin Microperfusion, Hydration, Elasticity, and Barrier Function
Study identification
- NCT ID
- NCT02762032
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Ohio State University
- Other
- Enrollment
- 45 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- PrimaVie Herbal Supplement 125 Dietary Supplement
- PrimaVie Herbal Supplement 250 Dietary Supplement
Drug · Dietary Supplement
Eligibility (public fields only)
- Age range
- 30 Years to 65 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2016
- Primary completion
- Nov 30, 2018
- Completion
- Nov 30, 2019
- Last update posted
- Jul 23, 2017
2016 – 2019
United States locations
- U.S. sites
- 3
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| OSU Hospital East | Columbus | Ohio | 43205 | Recruiting |
| Davis Heart and Lung Research Institute | Columbus | Ohio | 43210 | Recruiting |
| Martha Morehouse Medical Plaza 2050 Kenny Road | Columbus | Ohio | 43221 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02762032, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 23, 2017 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02762032 live on ClinicalTrials.gov.